The CDC recommends a single dose of any FDA-approved RSV vaccine for all adults ages 75 years and older, as well as for 60- ...

Wisconsin DHS Respiratory Disease Epidemiologist Thomas Haupt told the Journal Sentinel in an email the department's most ...

For most people RSV is like a cold, but for infants and older people it can lead to serious infections. Here's what to know.

The CDC’s overall snapshot of respiratory illness activity in Florida remains very high. The CDC has measured moderate levels ...

GSK and Pfizer's respiratory syncytial virus (RSV) vaccines will carry warnings that they can increase the risk of developing ...

The CDC reports that influenza A, COVID-19, norovirus, and RSV are on the rise this winter, with symptoms such as fever, ...

Reports of human metapneumovirus (HMPV), a common respiratory illness that causes flu- and cold-like symptoms, are growing ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

FDA updates safety labels for Pfizer's Abrysvo and GSK's Arexvy RSV vaccines, citing increased Guillain-Barré syndrome risk.

He also articulated a very specific doctrine about the role of an FDA commissioner, one that is limited in its power and ...

There has been an uptick in cases of norovirus (or “winter vomiting disease”), since it’s more common in the winter.

For immunocompromised individuals, antibody response to respiratory syncytial virus (RSV) vaccines is heterogeneous and about ...